A Critical Analysis of Clinical Outcomes Reported in Stem Cell Trials for Acute Myocardial Infarction: Some Thoughts for Design of Future Trials

Phase II Clinical Research Design in Cardiology

(2013) Joshua M. Hare et al.   CIRCULATION

Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function

(2011) Jay H. Traverse   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction

(2010) Johanna A. Miettinen et al.   Clinical Research in Cardiology

Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study)

(2010) K. A. A. Fox et al.   EUROPEAN HEART JOURNAL

Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study

(2010) J. O. Beitnes et al.   European Journal of Echocardiography

Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: Results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac Magnetic Resonance Imaging substudy

(2009) Thorsten Dill et al.   AMERICAN HEART JOURNAL

Clinical Outcome 2 Years After Intracoronary Administration of Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

(2009) Birgit Assmus et al.   Circulation-Heart Failure

Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up

(2009) F. Cao et al.   EUROPEAN HEART JOURNAL

Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial

(2009) G. P. Meyer et al.   EUROPEAN HEART JOURNAL

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial

(2009) Michał Tendera et al.   EUROPEAN HEART JOURNAL

Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarcti

(2009) Volker Schächinger et al.   EUROPEAN JOURNAL OF HEART FAILURE

Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study

(2009) J O Beitnes et al.   HEART

Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy

(2009) J. A Miettinen et al.   HEART

The BALANCE Study

(2009) Muhammad Yousef et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction

(2008) H. V. Huikuri et al.   EUROPEAN HEART JOURNAL

Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction

(2007) Jaroslav Meluzín et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY